J.W. Cole Advisors, Inc. Amgen Inc Transaction History
J.W. Cole Advisors, Inc.
- $2.33 Billion
- Q3 2024
A detailed history of J.W. Cole Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 15,774 shares of AMGN stock, worth $4.71 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
15,774
Previous 14,313
10.21%
Holding current value
$4.71 Million
Previous $4.47 Million
13.64%
% of portfolio
0.22%
Previous 0.21%
Shares
20 transactions
Others Institutions Holding AMGN
# of Institutions
3,102Shares Held
418MCall Options Held
7.27MPut Options Held
6.3M-
Vanguard Group Inc Valley Forge, PA51.9MShares$15.5 Billion0.32% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.8 Billion0.33% of portfolio
-
State Street Corp Boston, MA29MShares$8.66 Billion0.4% of portfolio
-
Morgan Stanley New York, NY14.4MShares$4.29 Billion0.35% of portfolio
-
Primecap Management CO Pasadena, CA14.3MShares$4.26 Billion3.44% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $160B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...